Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

VERU INC. (VERU) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

VERU INC. (VERU), most recent 12 months reported: net loss $13.61M, free cash flow -$26.04M. Latest balance sheet on file: liquid cash $25.79M. From SEC filings. Others in Pharmaceutical Preparations: Tyra Biosciences, Inc. · UNICYCIVE THERAPEUTICS, INC. · Valion Bio, Inc. · Vera Therapeutics, Inc. · Viking Therapeutics, Inc. · WHITEHAWK THERAPEUTICS, INC. · XBiotech Inc. · EXICURE, INC.

Stock screener

Watchlist